Top compounds associated with response to OR2T5


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.078 0.02
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.084 0.02
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC 0.082 0.02
mRNA decitabine CTRPv2 pan-cancer AAC -0.06 0.03
mRNA methylstat CTRPv2 pan-cancer AAC -0.09 0.03
mRNA cimetidine CTRPv2 pan-cancer AAC 0.14 0.03
mRNA CHIR-99021 CTRPv2 pan-cancer AAC -0.071 0.03
mRNA RITA CTRPv2 pan-cancer AAC 0.075 0.03
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.065 0.04
mRNA Bortezomib CTRPv2 pan-cancer AAC -0.072 0.04
Download CSV